Current Report Filing (8-k)
December 09 2022 - 4:32PM
Edgar (US Regulatory)
0001418135FALSE00014181352022-12-052022-12-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 5, 2022
Keurig Dr Pepper Inc.
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | | | | |
| | | | |
| Delaware | | 001-33829 | | 98-0517725 |
| (State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
53 South Avenue, Burlington, Massachusetts 01803
(Address of principal executive offices, including zip code)
781-418-7000
(Registrant’s telephone number including area code)
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol | | Name of each exchange on which registered |
| Common stock | | KDP | | Nasdaq Stock Market LLC |
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 5, 2022, the Remuneration and Nomination Committee of the Board of Directors of Keurig Dr Pepper Inc. (the “Company”) approved certain compensatory arrangements for Robert Gamgort in connection with his reappointment as President and Chief Executive Officer of the Company effective as of November 9, 2022. In connection with his reappointment as President and Chief Executive Officer, Mr. Gamgort will receive an annual base salary of $1,500,000 and will be eligible to receive an annual bonus at a target level of 150% of his base salary, which arrangements will be effective retroactively to November 10, 2022.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | | | | | | | | | | | | | |
| | | | | |
| | KEURIG DR PEPPER INC. | |
| Dated: December 9, 2022 | | |
| | By: | /s/ Anthony Shoemaker |
| | | Name: | Anthony Shoemaker |
| | | Title: | Chief Legal Officer, General Counsel and Secretary |
Keurig Dr Pepper (NYSE:KDP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Keurig Dr Pepper (NYSE:KDP)
Historical Stock Chart
From Dec 2023 to Dec 2024
